Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Neuphoria Therapeutics Inc. (NASDAQ: NEUP) and Scancell Holdings plc. Upon closing of the proposed transaction, Neuphoria shareholders will own 14.5% of the combined company.
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Myseum Inc. (NASDAQ: MYSE), a privacy-first social media and technology innovator, is capturing investor and media attention this week as CEO Darin Myman takes to the airwaves, sharing his vision for how Myseum’s technology could dramatically disrupt the social media landscape as we know it. The market has taken notice. MYSE shares have been active this week , closing Wednesday, October 22, 2025, at $2.68 and surging to an intraday high of $3.07 on Thursday on strong volume — reflecting growing investor enthusiasm as the company’s technology gains wider recognition.
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
This payment represents the second milestone in the collaboration between Neuphoria and Merck, with Neuphoria potentially eligible for up to $450 million in additional milestone payments.
